{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:48:48Z","timestamp":1781304528746,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jaad.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T11:26:35Z","timestamp":1549884395000},"page":"403-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study"],"prefix":"10.1016","volume":"81","author":[{"given":"Federica","family":"Guicciardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Tavecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Colato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel Patrice","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Kanitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mitteldorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cribier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Gusdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiacomo","family":"Calzavara-Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Bielsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Fernandez-Figueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pilloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rongioletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.02.009_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ad.2012.09.007","article-title":"Drug-induced lupus erythematosus","volume":"105","author":"Pretel","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2019.02.009_bib2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","article-title":"Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus","volume":"97","author":"Sontheimer","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2019.02.009_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archderm.1945.01510210032007","article-title":"Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus","volume":"51","author":"Hoffman","year":"1945","journal-title":"Arch Derm Syphilol"},{"key":"10.1016\/j.jaad.2019.02.009_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clindermatol.2003.12.023","article-title":"Drug-induced lupus erythematosus","volume":"22","author":"Antonov","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib5","first-page":"3","article-title":"An update in drug-induced subacute cutaneous lupus erythematosus","volume":"23","author":"Michaelis","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2019.02.009_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autrev.2010.07.005","article-title":"Drug-induced lupus: an update","volume":"10","author":"Katz","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2019.02.009_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","article-title":"Drug-induced lupus: an update on its dermatologic aspects","volume":"18","author":"Marzano","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2019.02.009_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydroclorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2019.02.009_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1067\/mjd.2001.116583","article-title":"Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized","volume":"45","author":"Callen","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/0961203310370349","article-title":"Drug-induced subacute cutaneous lupus erythematosus","volume":"19","author":"Callen","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2019.02.009_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2004.10.003","article-title":"Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings","volume":"4","author":"Sontheimer","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2019.02.009_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/ijd.IJD_579_17","article-title":"Causality or relatedness assessment in adverse drug reaction and its relevance in dermatology","volume":"63","author":"Pande","year":"2018","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(05)77665-0","article-title":"Causality assessment of adverse drug effects: when is rechallenge ethically acceptable?","volume":"354","author":"Po","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2019.02.009_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2133.2011.10397.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart","volume":"165","author":"Marzano","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib15","first-page":"465","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.02.009_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00003727-198208000-00009","article-title":"Adverse drug reactions in the community health setting: approaches to recognizing, counseling and reporting","volume":"5","author":"Jones","year":"1982","journal-title":"Fam Community Health"},{"key":"10.1016\/j.jaad.2019.02.009_bib17","article-title":"Drug-induced cutaneous lupus erythematosus: 88 new cases","author":"Laurinaviciene","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1365-2133.1999.03118.x","article-title":"Lupus erythematosus with antiphospholipid syndrome and erythema multiforme-like lesions","volume":"141","author":"Marzano","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1468-3083.2005.01233.x","article-title":"Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature","volume":"19","author":"Aydogan","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.02.009_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0961203307087189","article-title":"Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions","volume":"17","author":"Marzano","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2019.02.009_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archderm.1963.01590200064012","article-title":"Lupus erythematosus and erythema multiforme-like lesions. A syndrome with characteristic immunological abnormalities","volume":"88","author":"Rowell","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/000155500750012289","article-title":"Erythema multiforme-like subacute cutaneous lupus erythematosus: a new variety?","volume":"80","author":"Massone","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.02.009_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0025-7125(16)30620-4","article-title":"Subacute cutaneous lupus erythematosus: a decade's perspective","volume":"73","author":"Sontheimer","year":"1989","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaad.2019.02.009_bib24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archderm.138.9.1175","article-title":"Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus","volume":"138","author":"Black","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jaad.2015.12.029","article-title":"Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE)","volume":"74","author":"Tiao","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","article-title":"Drug-induced, Ro\/SSA-positive cutaneous lupus erythematosus","volume":"139","author":"Srivastava","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib27","series-title":"Weedon's Skin Pathology","first-page":"63","article-title":"The lichenoid reaction pattern ('interface dermatitis')","author":"Patterson","year":"2016"},{"key":"10.1016\/j.jaad.2019.02.009_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2133.1988.tb02580.x","article-title":"Dust-like particles: a specific direct immunofluorescence pattern in sub-acute cutaneous lupus erythematosus","volume":"118","author":"Nieboer","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1365-2133.1998.02275.x","article-title":"The significance of the 'dust-like particles' pattern of immunofluorescence. A study of 66 cases","volume":"138","author":"Lipsker","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1365-2133.2001.04182.x","article-title":"Apoptosis in different cutaneous manifestations of lupus erythematosus","volume":"144","author":"Baima","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib31","unstructured":"Ho CH, Chauhan K. Lupus eryhtematosus, drug-induced. Treasure Island (FL): StatPearls Publishing; 2018-2017 Oct 6."},{"key":"10.1016\/j.jaad.2019.02.009_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1610-0387.2008.06806.x","article-title":"Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature","volume":"6","author":"Lorentz","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2019.02.009_bib33","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archderm.137.9.1196","article-title":"Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases","volume":"137","author":"Callen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib34","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1067\/mjd.2001.114565","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"44","author":"Bonsmann","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib35","first-page":"889","article-title":"Drug-induced lupus erythematosus with emphasis on skin manifestation and the role of anti-TNF\u03b1 agents","volume":"10","author":"Dalle Vedove","year":"2012","journal-title":"J Deutsch Dermatol Gesel"},{"key":"10.1016\/j.jaad.2019.02.009_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2019.02.009_bib37","first-page":"12","article-title":"Lamotrigin induced subacute cutaneous lupus erythematosus","volume":"18","author":"Cabanillas","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2019.02.009_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40801-016-0067-4","article-title":"Drug-induced subacute cutaneous lupus erythematosus associated with proton-pump inhibitors","volume":"3","author":"Aggarwal","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jaad.2019.02.009_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"Gr\u00f6nhagen","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000247739","article-title":"Systemic lupus erythematosus exacerbated by piroxicam","volume":"182","author":"Roura","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2019.02.009_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/120347540300700310","article-title":"Subacute cutaneous lupus erythematosus induced by nifedipine","volume":"7","author":"Gubinelli","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2019.02.009_bib42","first-page":"213","article-title":"Nitrendipine-induced subacute cutaneous lupus erythematosus","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib43","article-title":"Secukinumab-induced subacute-cutaneous lupus erythematosus","author":"Wehrmann","year":"2017","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2019.02.009_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2230.2004.01527.x","article-title":"Subacute cutaneous lupus erythematosus associated with leflunomide","volume":"29","author":"Kerr","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2003.019323","article-title":"Lupus erythematosus with leflunomide: induction or reactivation?","volume":"64","author":"Gensburger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2019.02.009_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1751-2980.2011.00522.x","article-title":"Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab","volume":"12","author":"Verma","year":"2011","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jaad.2019.02.009_bib47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-006-0222-5","article-title":"Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative","volume":"26","author":"Lampropoulos","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2019.02.009_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jns.12218","article-title":"Drug-induced cutaneous lupus erythematosus after immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a case series","volume":"22","author":"Adrichem","year":"2017","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jaad.2019.02.009_bib49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.det.2010.03.007","article-title":"Innovative management of lupus erythematosus","volume":"28","author":"Knott","year":"2010","journal-title":"Dermatol Clin"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219302634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219302634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:51:12Z","timestamp":1759272672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219302634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0190962219302634"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.02.009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735094551.793559119","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}